AI (artificial intelligence) is rapidly gaining traction in mental health care, and for good reason. It offers the potential to streamline care, uncover clinical insights, and broaden access to ...

It’s no secret that many in the diabetes community use medications in ways that aren’t FDA-approved and deviate from what the product labeling says, otherwise known as “ off-label use.” In particular, ...

Pharmaceutical companies operating in the EU will need to collect and report information on the off-label use of their medicines under new obligations making their way from draft to final form at the ...

Health Canada last week issued a notice clarifying the circumstances in which the off-label use of an authorized drug in a clinical trial would not be considered investigational. The agency says the ...

Clinicians are increasingly prescribing GLP-1 receptor agonists, metformin, and SGLT-2 inhibitors—drugs approved for type 2 diabetes—to people with type 1 diabetes to improve weight, blood sugar ...

The use of antipsychotic medications for purposes other than those officially approved is common among older adults in Finland. This emerges from a large registry study conducted by the University of ...

A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities ...